has not been demonstrated in this model. Because of the continued mitochondrial oxidant stress in these animals, this is a critical question.
Liver regeneration is a vital process for survival after a toxic insult (Chanda and Mehendale, 1996) . Regeneration ensures the replacement of necrotic cells and the full recovery of organ function. Since hepatocytes are mostly in a quiescent state (G 0 ), the regeneration process requires entry into the highly regulated cell cycle (Fausto, 2000) .
The first step of this process is the priming of hepatocytes by cytokines such as TNF-α and IL-6 (Akerman et al., 1992; Cressman et al., 1996) , which makes cells more responsive to growth factors (Fausto et al., 1995) . The exposure to growth factors such as hepatocyte growth factor or transforming growth factor-α results in the expression of cell cycle proteins, e.g., cyclins and cyclin-dependent kinases, and cell cycle inhibitors, e.g., p21 and p27 (Fausto, 2000) . The induction of cyclin D 1 is considered a marker of cell cycle progression in hepatocytes (G 1 phase) (Albrecht and Hansen, 1999) . Once hepatocytes express cyclin D 1 , they have passed the G 1 restriction point and are committed to DNA replication (Fausto, 2000) . Interestingly, growth factors also induce inhibitors of the cell cycle, e.g., p21 (Albrecht et al., 1998) . The simultaneous expression of activators and repressors of the cell cycle allows a sensitive regulation of liver regeneration (Fausto, 2000) .
The aim of our investigation was to evaluate if a treatment regimen with intravenous GSH that mainly scavenges peroxynitrite, has a long-term protective effect against AAPinduced liver injury and enhances survival in this model. Furthermore, we investigated if 
MATERIALS AND METHODS
Animals. Male C3Heb/FeJ mice with an average weight of 18 to 20 g were purchased from Jackson Laboratory (Bar Harbor, Maine) and housed in an environmentally controlled room with 12 h light/dark cycle and free access to food (certified rodent diet no. 8640, Harlan Teklad, Indianapolis, IN) and water. The experimental protocols followed the criteria of University of Arkansas for Medical Sciences and the National Research Council for the care and use of laboratory animals in research. All animals were fasted overnight before the experiments. Animals received an intraperitoneal injection of 300 mg/kg AAP (Sigma Chemical Co., St. Louis, MO) between 8 and 9 am. AAP was dissolved in warm saline (15 mg/ml). Some groups of animals were treated intravenously with 200 mg/kg (0.65 mmol/kg) of GSH between 0 -3 h after AAP administration. GSH was dissolved in phosphate-buffered saline (25 mg/ml). Other animals were treated s.c.
with 450 µg/kg recombinant murine IL-6 (R&D Systems, Minneapolis, MN) 24 h before AAP. All animals were offered food again at 9 h after AAP treatment.
Experimental Protocols. At selected times after AAP treatment, the animals were killed by cervical dislocation. Blood, which was drawn from the vena cava with a syringe, was either added to a heparinized tube and centrifuged to obtain plasma or added to a sterile tube and allowed to clot to obtain serum. Plasma was used for determination of alanine aminotransferase (ALT) activities. Immediately after collecting the blood, the livers were excised and rinsed in saline. A small section from each liver was placed in 10% phosphate buffered formalin to be used in immunohistochemical analysis. A portion of the remaining liver was frozen in liquid This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on September 3, 2003 as DOI: 10.1124 at ASPET Journals on July 13, 2017 jpet.aspetjournals.org Downloaded from nitrogen and stored at -80° C for later analysis of glutathione and cell cycle protein expression.
Methods. Plasma ALT activities were determined with the test kit DG 159-UV (Sigma Chem. Co., St. Louis, MO) and expressed as IU/liter. Serum levels of interleukin-6 were determined with a murine IL-6 ELISA kit (R&D Systems, Minneapolis, MN). Total soluble GSH and GSSG were measured in the liver homogenate with a modified method of Tietze as described in detail (Jaeschke and Mitchell, 1990) . Briefly, the frozen tissue was homogenized on ice in 3% sulfosalicylic acid containing 0.1 mM EDTA. An aliquot of the homogenate was added to 10 mM N-ethylmaleimide (NEM) in potassium phosphate buffer (KPP) and another aliquot was added to 0.01 N HCl. The NEM-KPP sample was centrifuged and the supernatant was passed through a C 18 cartridge to remove free NEM and NEM-GSH adducts (Sep-pak; Waters Associates, Waltham, MA). The HCl sample was centrifuged and the supernatant was diluted with KPP. All samples were assayed using dithionitrobenzoic acid. All data are expressed in GSH-equivalents.
Histology and immunohistochemistry. Formalin-fixed tissue samples were embedded in paraffin and 5 µm sections were cut. Replicate sections were stained with hematoxylin and eosin (H&E) for evaluation of oncotic necrosis (Gujral et al., 2001 (Gujral et al., , 2002 . Necrotic cells were identified using the following morphological criteria: increased eosinophilia, cell swelling, cell lysis, karyorhexis and karyolysis. The percent of necrosis was estimated by evaluating the number of microscopic fields with necrosis compared to the entire cross section. In general, necrosis was estimated This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on September 3, 2003 as DOI: 10.1124 at ASPET Journals on July 13, 2017 jpet.aspetjournals.org Downloaded from at low power (x100); questionable areas were evaluated at higher magnification (x200 or x400). The pathologist (A.F.) evaluated all histological sections in a blinded fashion. Sections were also stained for the proliferating cell nuclear antigen (PCNA) using a rabbit polyclonal anti-PCNA antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and standard immunohistochemical procedures as described in detail (Chosay et al., 1998) .
Western blot analyses. Expression of the cell cycle proteins cyclin D 1 and p21 as well as the proliferating cell nuclear antigen (PCNA) were analyzed by Western blotting as described in detail (Bajt et al., 2000) . Briefly, freshly excised liver was homogenized in 25 mM HEPES buffer pH 7.5 containing 5 mM EDTA, 2 mM dithiothreitol, 1% CHAPS, 1 µg/ml pepstatin, leupeptin, and aprotinin. Homogenates 
RESULTS
To investigate a long-term beneficial effect of glutathione treatment against AAPinduced liver injury, animals received an intravenous dose of 200 mg/kg of GSH at 1.5 h after intraperitoneal administration of 300 mg/kg AAP. We previously showed that this dose of AAP induced peroxynitrite formation and caused severe liver injury at 6 h, which was substantially reduced by GSH treatment (Knight et al., 2002) . In agreement with these previous data, we observed significant increases in plasma ALT levels and histological evidence of centrilobular necrosis at 6 h after AAP treatment alone ( Figure 1A We previously showed that GSH treatment at 1.5 h after AAP did not prevent the mitochondrial oxidant stress 6 h after AAP administration (Knight et al., 2002) . hepatic GSH levels and 4.5-fold higher GSSG concentrations at 24 h after AAP (Figure 2A ,B). This resulted in an increase of the hepatic GSSG-to-GSH ratio from 0.4 ± 0.1 in controls to 6.5 ± 1.2 in AAP-treated mice (P <0.05). Animals receiving GSH had liver glutathione content similar to untreated controls ( Figure   2A ) but showed significantly elevated levels of GSSG ( Figure 2B ). The GSSG-to-GSH ratio (1.7 ± 0.1) was significantly reduced compared to AAP alone.
To investigate how the time of treatment with GSH affected the protective effect, animals were treated with GSH at the same time as AAP or at 1.5, 2.25 or 3 h after AAP. Based on plasma ALT activities and histological evaluation of necrosis, the best protection was observed with GSH treatment at the same time as AAP ( Figure 3A ,B). A significantly reduced injury at 24 h was also found when the animals were treated 1.5 h after AAP.
However, neither treatment at 2.25 nor at 3 h had a statistically significant effect on plasma ALT activities ( Figure 3A ,B). Although not significant, the area of necrosis still showed a trend to reduced injury ( Figure 3B ). In addition, none of the GSH-treated animals died. This was in contrast to the 50% mortality in animals, which received only AAP.
To administration ( Figure 4B ). All controls and AAP-treated animals had low hepatic protein levels of PCNA ( Figure 5A ). In contrast, hepatic PCNA levels progressively increased in GSH-treated animals from 12 h -48 h after AAP ( Figure 5B ). Since it is known that cell cycle inhibitors are also activated during regeneration (Albrecht et al., 1998) , we evaluated the expression of the cell cycle inhibitor p21. This protein was not expressed in controls and was not up regulated after AAP treatment ( Figure 6A ). However, in livers of GSH-treated animals, p21 expression was faintly detectable at 6 and 12 h and strongly expressed at 24 and 48 h after AAP ( Figure 6B ). To assess when GSH has to be administered to induce cell cycle activation, animals were treated with GSH at various times after AAP injection. Analysis for cyclin D 1 expression showed that GSH treatment at the time of AAP administration or at 1.5 h and at 2.25 h after AAP caused cyclin D 1 expression at 24 h ( Figure 7) . GSH administration at 3 h had no effect. It is well established that liver regeneration is a multi-step process. Priming of hepatocytes by cytokines such as TNF-α and IL-6 is the initial event (Fausto, 2000) . To investigate a potential involvement of IL-6 in the regeneration process of AAP/GSHtreated animals, IL-6 formation was measured. Serum concentrations of IL-6 progressively increased after AAP administration reaching peak levels of almost 400% above baseline at 24 h ( Figure 9 ). In contrast, serum IL-6 values in GSH-treated animals did not significantly increase during the entire 48 h observation period ( Figure 9 ). Since pretreatment with IL-6 can enhance regeneration and protect against ischemiareperfusion injury (Selzner et al., 1999) , we treated the animals with similar doses of murine recombinant IL-6 (450 µg/kg) 24 h before AAP. However, IL-6 treatment had no effect on AAP-induced severe centrilobular necrosis (data not shown).
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DISCUSSION
The objective of this investigation was to test the hypothesis that intervention with GSH after acetaminophen treatment has a long-term beneficial effect by reducing cell injury and promoting regeneration for a full recovery and survival. Our previous data showed that treatment with GSH at 1.5 h and later accelerated recovery of mitochondrial GSH levels, attenuated nitrotyrosine formation and reduced liver cell injury up to 6 h after AAP treatment without affecting mitochondrial oxidant stress (Knight et al., 2002) . In contrast, GSH treatment at the same time as AAP administration had similar effects but eliminated the mitochondrial oxidant stress. We concluded from these results that injection of GSH at 1.5 h or later minimally affected the detoxification of the reactive metabolite NAPQI but mainly acted as scavenger of peroxynitrite (Knight et al., 2002) . when substantial peroxynitrite was formed in hepatocytes (Knight et al., 2001) . Having less liver injury, AAP/GSH-treated animals ate similar to controls when food was offered again at 9 h after AAP administration. Consequently, these animals had supraphysiological levels of hepatic GSH at 24 h. These data are consistent with previous fasting/refeeding experiments (Wendel and Jaeschke, 1988). In contrast, the hepatic GSH levels in AAP-treated animals only recovered to levels of starved animals suggesting that animals with severe liver injury did not eat, which may have contributed to the progressive demise of these animals. Despite the lower GSH levels, GSSG concentrations and the GSSG-to-GSH ratio remained very high in AAP-treated animals. This indicates that there is a continuing oxidant stress in these hepatocytes. We showed previously that the majority of GSSG is located in mitochondria at 6 h (Knight et al., 2001 ) as well as 24 h (Jaeschke, 1990). Although the GSH-treated animals had elevated GSSG levels, the GSSG-to-GSH ratio was only modestly increased. These data suggest a reduced mitochondrial oxidant stress in AAP/GSH-treated animals at 24 h compared to AAP alone. Thus, the increased oxidant stress in both groups of animals at 6 h got worse in AAP-treated animals but improved in the AAP/GSH-treated animals.
In addition to the reduced oxidant stress and tissue necrosis, all animals treated with GSH showed clear evidence of cell cycle activation and tissue regeneration. In order for hepatocytes to divide (mitosis), they have to leave the resting state (G 0 ) and go through the cell cycle with DNA synthesis (S-phase) and mitosis (M-phase) (Fausto, 2000) . To go through the sequence of these steps, the cell has to pass a number of checkpoints.
Expression of cyclin D 1 is a reliable marker that the cell has overcome a restriction point in G 1 and is irreversibly committed to DNA synthesis (G 1 /S transition) (Albrecht and Hansen, 1999) . Furthermore, PCNA is synthesized in G 1 and S phase resulting in prominent nuclear staining for this antigen in proliferating cells (Bravo and MacDonaldBravo, 1987) . In addition to promoters of the cell cycle, cell cycle inhibitors are also expressed in the regenerating liver (Albrecht et al., 1998) Hepatocyte regeneration is a multi-step process requiring cytokines and growth factors for its initiation (Fausto et al., 1995) . Cytokines prime hepatocytes for the activating effect of growth hormones (Fausto, 2000) . Neutralizing TNF-α or eliminating the synthesis of IL-6 prevented a regenerative response after partial hepatectomy (Akerman et al., 1992; Cressman et al., 1996) . In addition, pretreatment with recombinant IL-6
promoted liver regeneration in IL-6 gene-deficient mice (Cressman et al., 1996) and This article has not been copyedited and formatted. The final version may differ from this version. attenuated liver injury during ischemia-reperfusion (Selzner et al., 1999) . Interestingly, IL-6 formation was only detectable in AAP-treated animals, which did not show signs of regeneration during the first 24 h. In contrast, GSH treatment eliminated IL-6 formation in AAP-treated mice. Moreover, pretreatment with a high dose of murine rIL-6, similar to previous successful experiments (Cressman et al., 1996; Selzner et al., 1999) , had no effect on AAP-induced liver injury. In contrast to these results, Chanda et al. (1995) showed that forcing hepatocytes into cell division with a low dose of thioacetamide protected rat livers from subsequent AAP-induced hepatotoxicity. This demonstrates that an early regeneration response can reduce toxic liver injury. On the other hand, treatment with growth factors that stimulate mitosis did not prevent acetaminophen-induced liver failure in dogs (Francavilla et al., 1993) . These data suggest that regeneration cannot rescue severely injured cells. Our data agree with these results. The severely damaged hepatocytes after AAP were not able to enter the cell cycle and mount a regenerative response despite the formation of IL-6. However, blunting the progression of the injury by GSH treatment preserved the capacity of the liver to regenerate and therefore to recover from the insult. Interestingly, in contrast to the regenerative response after partial hepatotectomy (Cressman et al., 1996) , regeneration after AAP-induced liver injury appears to be independent of IL-6. One possible explanation for these findings could be that the TNF-α generated in AAP-treated animals may stimulate hepatic regeneration by directly, i.e., independent of IL-6, inducing the expression of transforming growth factor-α (TGF-α), which is a potent mitogen for hepatocytes
(Gallucci et al., 2000).
